###### Strengths and limitations of this study

-   EPIPAGE-2 is the first national cohort study to report variability of neonatal care practices for very preterm babies born at 27 to 31 weeks' gestation and examine how they are related in neonatal intensive care units.

-   Practices were analysed using five domains of care: respiratory, cardiovascular, nutrition, pain and neurodevelopmental care.

-   Hierarchical cluster analysis was used to examine the association between domains within units in France and clusters' relationships with outcomes at hospital discharge and at 2 years corrected age are reported.

-   The description of care domains was limited to variables collected for the study and specific pathways of care implementation were not explored.

-   A lack of detailed information on organisational and unit cultural factors limit the understanding of pathways leading to different care patterns.

Introduction {#s1}
============

It is well described that some variations in clinical care are unwarranted because they cannot be explained by type or severity of illness or by patient preferences.[@R1] Local medical opinion appears more important than science in determining how medical care is delivered. In the field of neonatal care, most of the decisions neonatologists have to take are for care where the evidence of benefit is not well established, or where possible benefit is accompanied by significant risk of adverse effects.[@R2] Neonatal intensive care is an extremely complex care system requiring expertise in conventional fields of medicine as well as in ethics, in babies' and parents' physiological and emotional needs, and also in the development of a preterm neonate.[@R4] With increasing knowledge on the role of environmental exposures on newborn neurodevelopment and maternal-newborn bonding,[@R5] identifying overuse of treatment with potential adverse effects has become more critical for neonatologists. Thanks to numerous collaborative quality improvement initiatives,[@R6] unwarranted variation has been described in the use of health services or conventional care practices,[@R2] for example, variations in the use of antibiotics or ventilator treatment in Norway.[@R3] To our knowledge, no study has tried to investigate how care practices in different areas of neonatal care are intertwined within units. In addition, practices are usually reported for babies born extremely preterm[@R10] although babies born between 27 and 31 weeks of gestation (WG) represent a higher proportion of preterm babies at high risk of mortality and disabilities.

The EPIPAGE-2 cohort study was designed to measure survival and morbidity after very preterm birth in France.[@R13] This study is a secondary analysis of EPIPAGE-2 data. We wanted to know if there were inter-relationships between the use of neurodevelopmental care and more conventional care practices---for example, if higher use of neurodevelopmental care was associated with less frequent use of invasive practices---and, if so, if this was associated with subsequent outcomes. Our first objective was thus to explore if patterns of units could be identified for babies born between 27 and 31 WG. The second objective was to report outcomes at discharge and at 2 years corrected age (CA) in relation to any clusters identified. We hypothesised that patterns of care within units are not distributed at random and that observing differences in outcomes could reveal opportunities to decrease adverse effects of unnecessary care.

Population and methods {#s2}
======================

EPIPAGE-2 study is a national population-based cohort study launched in France in 2011 and scheduled to follow children up to the age of 12 years. Eligible participants included all babies live or stillborn, and all terminations of pregnancy between 22 and 34 completed WG.[@R13] Infants discharged alive were included in follow-up and evaluated at 2 years CA.

For this study, inclusion criteria were live birth between 27 and 31 WG, hospitalised in the same level III neonatal intensive care units (NICUs) until day 7 of age. Level III NICUs are located in centres that provide obstetric and ongoing neonatal intensive care. In addition, some of these NICUs also provide surgical care. Neonates were included between March and October 2011. Exclusion criteria were death in the delivery room, presence of severe congenital malformations that might affect survival,[@R14] transfer to another unit before day 7, and admission to a NICU with fewer than 20 neonates included in the study.

Patient and public involvement {#s2-1}
------------------------------

Patients were not involved in setting the research question or the outcome measures, nor were they involved in developing plans for design of the study. Parents demonstrated overwhelming support for the study through high follow-up rates. EPIPAGE-2 maintains contact with parents in the cohort through letters, newsletters and its website (<https://epipage2.inserm.fr/index.php/fr/cote-parents/temoignages>). National parents' associations assisted with the dissemination of the results.

Data collection {#s2-2}
---------------

Data were obtained through questionnaires completed in maternity units and throughout the neonatal hospitalisation by perinatal teams, and through medical and parental questionnaires at 2 years of age.

### Practices {#s2-2-1}

Evaluated care practices, collected during the first week of life, were categorised into five domains: three related to conventional care (respiratory, cardiovascular, nutrition), and two to neonates' and parents' developmental and emotional needs (pain and neurodevelopmental care). Practices, considered as markers of interest for these different domains, were: administration of surfactant and mechanical ventilation at 24 hours of life for the respiratory domain; systematic echocardiographic screening of patent ductus arteriosus (PDA) before day 3, treatment with vasoactive amines, and PDA treatment with ibuprofen for the cardiovascular domain; early enteral feeding (before day 2) for the nutrition domain; treatment with opioids, sedatives-hypnotics, or general anaesthetics (O-SH-GA), and at least one assessment of procedural or prolonged pain, for the pain domain; permanent incubator cover, kangaroo care during the first 3 days of life, parental involvement in feeding support (feed with support or swaddling by parents, or during skin-to-skin contact, or opportunity for the baby to suck a dummy offered by parents during tube feeding) and breast contact (with or without nutritive or non-nutritive sucking) for neurodevelopmental care. Most care practices that were studied were considered markers of evidence-based quality during the time period of the study but appropriate utilisation rates are unknown. In the group of conventional care, all can be considered as 'necessary care'[@R2] for some infants (treatment rate reflects the prevalence of a clinical condition in the population), but as 'preference-sensitive care'[@R2] for others (that is indications and health benefits are unclear or controversial within the medical community). For example, mechanical ventilation at 24 hours of life is dependent not only on the child's respiratory condition but also on medical opinion towards early weaning from mechanical ventilation. Variations between units in conventional care may be observed but should be limited. Cares studied in the neurodevelopmental care domain respond mainly to the definition of 'preference-sensitive care'. For example, kangaroo care before day 3 depends on the clinical condition of the child and is highly dependent on the team opinion.[@R15] Greater variations between units were thus expected in this domain. For ethical reasons, assessment of pain, in this highly vulnerable population, should be close to 100% but treatment with O-SH-GA is dependent on unit culture and case-mix.

### Maternal, obstetric and neonatal characteristics {#s2-2-2}

Maternal characteristics were: age (years), birth in France, parents' socio-economic status (professional, intermediate, administrative or public service, self-employed or student, shop assistants or service workers, manual workers and unknown occupation); obstetric characteristics: singleton pregnancy, antenatal steroids and vaginal delivery; neonatal characteristics: gestational age (GA, weeks), sex (male/female) and small-for-gestational age (SGA) defined as birth weight less than the 10^th^ percentile for GA and sex based on French intrauterine growth curves[@R17] and severe neonatal morbidity,[@R18] including any of the following complications: severe bronchopulmonary dysplasia (administration of oxygen for at least 28 days plus need for 30% or more oxygen and/or mechanical ventilation or continuous positive airway pressure at 36 weeks' postmenstrual age), necrotising enterocolitis stage 2 to 3, severe retinopathy of prematurity stage \>3 or any of the following severe cerebral abnormalities on cranial ultrasonography: intraventricular haemorrhage grade III or IV or cystic periventricular leukomalacia.

### At 2 years of age {#s2-2-3}

A medical questionnaire collected information on cerebral palsy (CP) and sensory deficits (bilateral or unilateral blindness or deafness).[@R19] CP was defined according to the Surveillance of Cerebral Palsy in Europe network,[@R20] and severity classified with Gross Motor Function Classification System (GMFCS).[@R21] Severe neuro-motor or sensory disabilities were defined as non-ambulatory CP (GMFCS level 3 to 5) or severe visual or auditory impairment; moderate disability included GMFCS level 2 CP and/or moderate visual or auditory impairment.[@R19] The parental questionnaire included the second version of the 24 month Ages and Stages Questionnaire (ASQ),[@R22] covering five developmental domains. ASQs were analysed if completed between 22 and 26 months CA in children without CP, deafness or blindness. Results are reported as ASQ score below threshold, defined as a score lower than two SD from the mean for any of the five ASQ domains.[@R22]

Outcomes {#s2-3}
--------

Outcomes are reported for babies admitted to NICUs and for survivors at 2 years CA. We first consider mortality and mortality or severe neonatal morbidities at hospital discharge, and mortality and mortality or severe/moderate neuro-motor or sensory disabilities at 2 years CA. We also report proportions of children with CP, and proportions of children with an ASQ below threshold at 2 years CA.

Statistical analysis {#s2-4}
--------------------

To identify clusters of units, we first calculated observed proportions of each practice in each unit, using estimated expected proportions to take into account differences in the populations cared for in each unit. Expected proportions were obtained using logistic regression models including a priori identified confounders ([online supplementary table 1](#SP1){ref-type="supplementary-material"}). Units were then classified into clusters using ascending hierarchical analysis,[@R23] carried out on observed/expected rather than observed proportions. Second, we compared practices for clusters of units, after adjustment for potential confounders. To help understand differences between the clusters, we present comparisons of unit and individual (maternal, obstetrical and neonatal) characteristics. Third, we describe maternal, obstetric and infant characteristics for children with and without missing data for CP and ASQ as well as the proportions of missing data for CP and ASQ in each cluster. We then compared outcome measures between clusters after adjustment for a priori identified potential confounders (maternal age, maternal country of birth, parents' socio-economic status, singleton pregnancy, antenatal corticosteroids, mode of delivery, GA, sex and SGA). To account for the non-independence of babies within units, generalised estimating equations were used. Results are given for complete cases and after multiple imputation. Missing data were imputed by chained equations using the Statistical Analysis System (SAS) Multiple Imputation (MI) procedure.[@R24] Imputation model variables included both those potentially predicting non-response and/or outcomes (maternal age and country of birth, parity, parental socio-economic status, antenatal steroids, caesarean section, multiple pregnancy, GA, sex, SGA, inborn status, surfactant, postnatal steroids, severe neonatal morbidities and use of breast milk at discharge), and outcomes (CP, neuro-motor or sensory disabilities and ASQ score below threshold), as previously reported.[@R19] We generated 50 independent imputed data sets with 30 iterations each. Estimates were pooled according to Rubin's rule.[@R25] All tests were two-sided with P values\<0.05 considered significant. All analyses were performed with SAS software (V.9.4).
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Results {#s3}
=======

Population {#s3-1}
----------

Among the overall cohort, 2479 neonates were born alive in a level III NICU between 27 and 31 WG. After applying exclusion criteria, 2135 were included in the study ([figure 1](#F1){ref-type="fig"}). At 2 years CA, 2024 children were eligible for follow-up; medical and parental questionnaires were available for 1717 and 1747, respectively, with ASQ data suitable for analysis for 1225 children.

![Flowchart of the study population. ASQ, Ages and Stages Questionnaire. ^a^Small units are units with less than 20 inclusions in EPIPAGE-2.](bmjopen-2019-035075f01){#F1}

Distribution of care between units {#s3-2}
----------------------------------

Of the 66 level III NICUs existing in France in 2011, 13 were excluded because \<20 babies were eligible for inclusion in this study. Large variabilities were observed between units in the administration of care in the five evaluated domains ([figure 2](#F2){ref-type="fig"}). For example, median and (IQR) were 23% (15 to 46) for systematic echocardiographic screening of PDA before day 3, 33% (22 to 45) for treatment with O-SH-GA, and 29% (17 to 52) for kangaroo care during the first 3 days of life. Systematic PDA screening was never reported for babies born after 29 weeks. In the hierarchical analysis, three clusters of units were identified ([figure 3](#F3){ref-type="fig"}). Half of the units (26/53) were in Cluster 1. The distribution of the studied practices in each investigated domain and by cluster is reported in [table 1](#T1){ref-type="table"}. Higher proportions of infants weaned from mechanical ventilation before 24 hours of life, receiving early enteral feeding and neurodevelopmental care practices were observed in Cluster 1, higher screening of PDA and of pain in Cluster 2, and higher use of respiratory, cardiovascular and pain treatments in Cluster 3. The mean length of stay in the first unit was 49 days (SD 31), 44 days (SD 27) and 45 days (SD 29) in Clusters 1, 2 and 3, respectively (p=0.001).

###### 

Proportions of practices in each investigated domain for the study population and by cluster of units

                                                                                        Cluster \* 1   Cluster \* 2   Cluster \* 3   Adjusted p value                    
  ------------------------------------------------------------------------------------- -------------- -------------- -------------- ------------------ --------- ------ -------------
  Respiratory                                                                                                                                                            
   Surfactant administration                                                            612/1108       55.2           213/395        53.9               423/615   68.8   \<0.001†
   Mechanical ventilation at 24 hours of life                                           177/1096       16.2           86/389         22.1               219/601   36.4   \<0.001†
  Cardiovascular                                                                                                                                                         
   Systematic screening of PDA with echocardiography before day 3                       240/1088       22.1           182/388        46.9               246/598   41.1   \<0.001‡
   Treatment with vasoactive amines                                                     44/1103        4.0            22/391         5.6                78/611    12.8   \<0.001§
   PDA treatment with ibuprofen                                                         186/1087       17.1           70/390         17.9               123/610   20.2   0.15‡
  Nutrition                                                                                                                                                              
   Early enteral feeding (before day 2)                                                 877/1069       82.0           263/372        70.7               429/598   71.7   \<0.001¶
  Pain                                                                                                                                                                   
   Treatment with O-SH-GA                                                               342/1113       30.7           109/396        27.5               307/614   50.0   \<0.001‡
   Procedural pain assessment (at least one assessment during the first week of life)   389/1118       34.8           170/398        42.7               181/619   29.2   \<0.001‡
   Prolonged pain assessment (at least one assessment during the first week of life)    785/1118       70.2           366/398        92.0               327/619   52.8   \<0.001‡
  Neurodevelopmental care                                                                                                                                                
   Permanent incubator cover during the first week of life                              889/1011       87.9           122/355        34.4               426/536   79.5   \<0.001‡
   Kangaroo care during the first 3 days of life                                        443/1038       42.7           95/388         24.5               106/563   18.7   \<0.001\*\*
   Parental involvement in feeding support †† during the first week of life             495/987        50.2           139/379        36.7               166/563   29.5   \<0.001\*\*
   Breast contact during the first week of life                                         138/1031       13.4           27/381         7.1                29/584    5.0    \<0.001\*\*

\*Clusters are defined according to the distribution of care within units using a hierarchical analysis.

†Adjusted for gestational age, antenatal corticosteroids and small-for-gestational age.

‡Adjusted for gestational age.

§Adjusted for gestational age and hypotension.

¶Adjusted for gestational age, small-for-gestational age and normal bowel frequency defined as at least one stool per day.

\*\*Adjusted for gestational age, type of pregnancy and mode of delivery.

††Parental involvement in feeding support was defined as a feed with support or swaddling by parents, or during skin-to-skin contact, or opportunity for the baby to suck a dummy offered by parents during tube feeding. Data are number of events/number in group and percentages. P values were estimated from a logistic model adjusted for specified variables.

O-SH-GA, opioids, sedatives-hypnotics, or general anaesthetics; PDA, patent ductus arteriosus.

![Distribution of the frequency of care practices in units for the study population a. The statistical unit is the neonatal unit (n=53). The vertical bar inside each box is the median, the right and left of the box indicate the IQR, the - bars indicate the 95^th^ percentiles, and the circles indicate outliers. ^a^Neonates born between 27 and 31 weeks of gestation, admitted between day 0 and 7 in a single level III neonatal intensive care unit and after exclusion of neonates with severe congenital malformations, as well as neonates born in units with less than 20 inclusions in EPIPAGE-2. ^b^Parental involvement in feeding was defined as a feed with support or swaddling by parents, or during skin-to-skin contact, or opportunity for the baby to suck a dummy proposed by parents during tube feeding. O-SH-GA, opioids, sedatives-hypnotics, or general anaesthetics; PDA, patent ductus arteriosus.](bmjopen-2019-035075f02){#F2}

![Dendrogram showing the distribution of NICUs among three clusters. Hierarchical cluster analysis was used to classify NICUs on the 13 ratios 'observed / expected' percentages of practices. The classification was performed using Ward\'s method with Euclidean distance. The dendrogram illustrates the results of the cluster analysis. Three main clusters were identified. NICU, neonatal intensive care unit.](bmjopen-2019-035075f03){#F3}

Units' characteristics by cluster {#s3-3}
---------------------------------

Differences between clusters were observed for the availability of neonatal surgery and training in neurodevelopmental care ([table 2](#T2){ref-type="table"}).

###### 

Units' characteristics according to the three clusters of units

                                                                     Cluster \* 1     Cluster \* 2     Cluster \* 3     P value†                  
  ------------------------------------------------------------------ ---------------- ---------------- ---------------- ---------- ------- ------ -------
  University hospital                                                21/26            80.8             7/11             63.6       8/16    50.0   0.11
  NICU only ‡                                                        14/26            53.8             8/11             72.7       12/16   75.0   0.31
  Number of beds, median (IQR)                                       10 (8 to 14)     11 (8 to 16)     12 (8 to 16)     0.61                      
  Annual number of admission before 31 weeks in 2011, median (IQR)   91 (75 to 118)   90 (64 to 112)   86 (64 to 119)   0.74                      
  Neonatal surgery available for                                                                                                                  
   Necrotising enterocolitis                                         22/26            84.6             9/11             81.8       7/16    43.8   0.012
   Patent ductus arteriosus                                          20/26            76.9             8/11             72.7       4/16    25.0   0.002
   Ventriculoperitoneal shunt                                        13/26            50.0             4/11             36.4       2/16    12.5   0.048
  Neurodevelopmental care training                                                                                                                
   NIDCAP                                                            7/26             26.9             2/11             18.2       1/16    6.3    0.023
   Sensory motor programme                                           2/26             7.7              5/11             45.5       1/16    6.3    
   Introductory course                                               9/26             34.6             1/11             9.1        5/16    31.3   
   No training                                                       8/26             30.8             3/11             27.3       9/16    56.3   

NICU only without paediatric intensive care unit

\*Clusters are defined according to the distribution of care within units using a hierarchical analysis.

†χ^2^ test for categorical variables or Kruskal-Wallis tests for quantitative variable.

‡Units admitting neonates only, without a paediatric intensive care unit.

NICU, neonatal intensive care unit; NIDCAP, Neonatal Individualised Developmental Care and Assessment Program.

In Clusters 1 and 2, similar proportions of units provided neurodevelopmental care training to staff, but the types of training were different. Units in Cluster 3 had a lower availability of neonatal surgery, and nearly 60% of did not provide any training in neurodevelopmental care.

Maternal and infant characteristics by clusters {#s3-4}
-----------------------------------------------

Differences between clusters were observed for maternal place of birth, mode of delivery and babies' sex; the GA distribution between clusters was not significantly different ([table 3](#T3){ref-type="table"}).

###### 

Maternal and infant characteristics for the study population and by cluster units

                                                                 Cluster \* 1   Cluster \* 2   Cluster \* 3   P value                    
  -------------------------------------------------------------- -------------- -------------- -------------- --------- --------- ------ -------
  Maternal characteristics                                                                                                               
   Maternal age                                                                                                                          
    \<25 years                                                   221/1118       19.8           67/398         16.8      111/619   17.9   0.29
    25 to 34 years                                               640/1118       57.2           248/398        62.3      353/619   57.0   
    [\>]{.ul}35 years                                            257/1118       23.0           83/398         20.9      155/619   25.0   
   Birth in France                                               879/1100       79.9           286/394        72.6      454/615   73.8   0.002
   Parents' socio-economic status †                                                                                                      
    Professional                                                 238/1055       22.6           97/382         25.4      122/596   20.5   0.053
    Intermediate                                                 213/1055       20.2           82/382         21.5      129/596   21.6   
    Administrative, public service, self-employed and students   288/1055       27.3           122/382        31.9      160/596   26.8   
    Shop assistants and service workers                          132/1055       12.5           35/382         9.2       92/596    15.4   
    Manual workers                                               143/1055       13.6           35/382         9.2       71/596    11.9   
    Unknown occupation                                           41/1055        3.9            11/382         2.9       22/596    3.7    
  Obstetric factors                                                                                                                      
   Singleton pregnancy                                           753/1118       67.4           269/398        67.6      406/619   65.6   0.72
   Antenatal steroids                                            995/1104       90.1           359/394        91.1      531/607   87.5   0.12
   Vaginal delivery                                              288/1113       25.9           136/393        34.6      169/615   27.5   0.004
  Neonatal characteristics                                                                                                               
   Gestational age, weeks                                                                                                                
   27                                                            168/1118       15.0           47/398         11.8      87/619    14.1   0.26
   28                                                            185/1118       16.5           65/398         16.3      105/619   17.0   
   29                                                            209/1118       18.7           74/398         18.6      113/619   18.3   
   30                                                            275/1118       24.6           113/398        28.4      132/619   21.3   
   31                                                            281/1118       25.1           99/398         24.9      182/619   29.4   
   Male                                                          557/1118       49.8           228/398        57.3      347/619   56.1   0.008
   Small-for-gestational age ‡                                   445/1118       39.8           170/398        42.7      248/619   40.1   0.58

Data are number of events/number in each group and percentage.

\*Clusters are defined according to the distribution of care within units using a hierarchical analysis.

†Defined as the highest occupational status of the mother and father, or mother only if living alone.

‡Small-for- gestational age was defined as birth weight less than the 10^th^ percentile for gestational age and sex based on French intrauterine ' growth curves (Ego 2016).

Outcomes {#s3-5}
--------

At 2 years CA, children without missing data for CP or ASQ were born more frequently to mothers with higher socio-economic status than children with missing data, but neonatal characteristics were similar ([online supplementary table 2](#SP1){ref-type="supplementary-material"}); proportions of children with missing data were also similar among clusters ([online supplementary table 3](#SP1){ref-type="supplementary-material"}). At discharge, no difference in outcomes was observed between Clusters 1 and 3 ([table 4](#T4){ref-type="table"}). Mortality was lowest in Cluster 2, with no difference between clusters in proportions of children who died or had severe neonatal morbidity. At 2 years CA, proportions of CP were no different between clusters but a higher proportion of children with an ASQ below threshold was observed in Cluster 2. After multiple imputation rates of CP were only slightly modified, a consistent increase was observed in each cluster in rates of ASQ scores below threshold.

###### 

Outcome at discharge from NICUs and at 2 years CA in the study population by cluster of units

                                                                           Cluster \* 1   Cluster \* 2   Cluster \* 3   P value                                               
  ------------------------------------------------------------------------ -------------- -------------- -------------- --------------------- --------- --------------------- -------
  Infants admitted to NICU                                                                                                                                                    
   At discharge                                                                                                                                                               
   Mortality                                                               63/1118        5.6 %          9/398          2.3 %                 29/619    4.7 %                 
   aOR (95% CI)†                                                                          1                             0.43 (0.20 to 0.93)             0.88 (0.51 to 1.54)   0.010
   Mortality or severe neonatal morbidity**‡**                             197/1118       17.7 %         58/398         14.7 %                100/619   16.2 %                
   aOR (95% CI)†                                                                          1                             0.84 (0.49 to 1.42)             0.93 (0.62 to 1.39)   0.72
   At 2 years CA                                                                                                                                                              
   Mortality                                                               68/1118        6.1 %          9/398          2.3 %                 34/619    5.5 %                 
   aOR (95% CI)†                                                                          1                             0.39 (0.18 to 0.85)             0.96 (0.56 to 1.67)   0.060
   Mortality or severe/moderate neuro-motor or sensory disabilities**§**   103/1118       9.3 %          17/398         4.3 %                 61/619    9.9 %                 
   aOR (95% CI)†                                                                          1                             0.46 (0.25 to 0.84)             1.13 (0.78 to 1.63)   0.010
  Survivors at 2 years CA                                                                                                                                                     
   Cerebral palsy                                                          54/1050        5.1%           14/389         3.6 %                 25/585    4.1 %                 
   aOR (95% CI)†                                                                          1                             0.57 (0.21 to 1.55)             0.81 (0.44 to 1.50)   0.41
   ASQ below threshold ¶                                                   420/989        42.5 %         195/375        52.7 %                260/553   47.6 %                
   aOR (95% CI)†                                                                          1                             1.49 (1.07 to 2.08)             1.17 (0.89 to 1.55)   0.042
   Complete cases analysis                                                                                                                                                    
   Cerebral palsy                                                          43/884         4.9%           11/327         3.4%                  20/506    4.0%                  
   aOR (95% CI)†                                                                          1                             0.63 (0.23 to 1.74)             0.86 (0.47 to 1.56)   0.64
   ASQ below threshold ¶                                                   245/650        37.7%          109/232        47.0%                 141/343   41.1%                 
   aOR (95% CI)†                                                                          1                             1.51 (1.07 to 2.14)             1.19 (0.86 to 1.64)   0.063

Data are number of events/number in each group and percentage, unless otherwise noted. Generalised Estimating Equations are used to take into account NICUs effects. Results are based on multiple imputations unless noted.

\*Clusters are defined according to the distribution of care within units using a hierarchical analysis.

†Adjusted for maternal age, maternal country of birth, type of pregnancy, mode of delivery, antenatal corticosteroids, GA, sex, small-for-gestational age (defined as birth weight less than the 10^th^ percentile for GA and sex based on French intrauterine growth curves (Ego 2016)) and parents' socio-economic status.

‡Severe neonatal morbidity was defined as severe bronchopulmonary dysplasia or necrotising enterocolitis stage 2 to 3 or severe retinopathy of prematurity stage \>3 or any of the following severe cerebral abnormalities on cranial ultrasonography: intraventricular haemorrhage grade III or IV or cystic periventricular leukomalacia (Ancel 2015).

§Moderate or severe neuro-motor or sensory disabilities. Severe neuro-motor or sensory disabilities: cerebral palsy GMFCS levels 3 to 5 and/or bilateral deafness and/or bilateral blindness; moderate neuro-motor or sensory disabilities: cerebral palsy GMFCS level 2 and/or unilateral deafness and/or unilateral blindness.

¶For each of the five domains of ASQ, a score of less than 2 SD below threshold of the US ASQ-3 reference was identified. If a score was below threshold in at least one domain, the ASQ was considered below threshold. Infants with cerebral palsy, deafness, blindness or severe congenital anomalies were excluded.

aOR, adjusted OR; ASQ, Ages and Stages Questionnaire; CA, corrected age; GA, gestational age; GMFCS, Gross Motor Function Classification System; NICU, neonatal intensive care unit.

Discussion {#s4}
==========

In this population-based cohort of babies born between 27 and 31 WG, we found variability in care practices between units. This occurred not only in the use of individual practices but also in which combinations of practices were used within units. Three clusters were identified with few differences between them in terms of baseline population characteristics. Despite different strategies of care, similar outcomes were observed between Clusters 1 and 3.

Cluster 2 had the lowest mortality at discharge but also the highest proportion of children with an ASQ below threshold at 2 years CA.

EPIPAGE-2 is a large, national cohort study with prospective enrolment of preterm babies that enabled us to focus on babies born between 27 and 31 WG. This is important as this population includes a larger number of babies when compared with the extremely preterm population but has been less well studied. Updated data on care practices and outcomes for these neonates may have an impact on public health by enabling neonatal teams to reconsider strategies for care provision. We included inborn babies only, as birth outside a level III unit is associated with an increased likelihood of death before discharge. Thus, outcomes are more likely to be related to units' practices than to characteristics of the populations admitted in each cluster. In addition, this strategy may help to reduce unmeasured variability, for example, due to differing clinical experiences of staff members. We also report issues at both discharge and 2 years CA; this enabled us to observe that the lower mortality at discharge in Cluster 2 was associated with a higher proportion of children with an ASQ score below threshold at 2 years CA, and thus at risk of having developmental or cognitive delay.[@R26] However, the use of parental questionnaires rather than objective assessment may be viewed as a limitation. Therefore results of the ASQ were not included in a composite outcome at 2 years CA to describe children with intact survival. Of note, unlike mortality, having an ASQ below threshold is not a rare event and the OR slightly overestimates the relative risk. Another limitation is that the investigation was restricted to care delivered during the first week of life as we were limited to practices collected in EPIPAGE-2. On the other hand, this also targets the most vulnerable time period for VPT babies. Particularly, the respiratory and cardiovascular practices studied are most reflective of intensive care provided during the first week of life. We were unable to quantify early non-invasive respiratory support. Recommendations, published after data collection commenced, are that protocols should be directed at avoiding mechanical ventilation where possible.[@R28] Hence low rates of mechanical ventilation at 24 hours of life may suggest the use of less invasive strategies in line with the implementation of these recommendations. Defining neurodevelopmental care with practices only is not ideal and does not consider whether units individualise care or have a family-centred care philosophy---both core concepts of neurodevelopmental care. Conversely, a high level of implementation of neurodevelopmental care practices has been considered as a marker for a unit's 'state of mind',[@R29] and our strategy to describe implementation of neurodevelopmental care may be helpful at a population level. We also did not consider whether babies were transferred to another hospital. However, the mean length of stay for babies included in our study was relatively high, and fewer than 50% were transferred after the first week of life (data not shown). The rate of loss to follow-up was another limitation, although the follow-up rate was high if one considers the size and the geographical dispersion of the cohort. We used multiple imputation to account for missing data; ORs were in the same direction in the complete cases analysis and after multiple imputation. We thus find it plausible that the results we observed are valid and that health outcome reflect units' policies. Finally, the paucity of information we had on 'supply-sensitive care' (referring to medical services for which usage rates are sensitive to the local availability of healthcare resources)[@R2] such as healthcare professionals' availability[@R30] was an obvious limitation.

The magnitude of absolute difference in care practices between clusters is difficult to interpret.[@R31] For example, a 15% difference for surfactant between Cluster 2 and 3 may be considered a small difference, but from an economic perspective, with regard to the cost of the surfactant, it could be considered big; more than 20% difference for kangaroo care during the first 3 days of life may be viewed as important for the infant neurodevelopment but also for parental bonding; and variations in the use of vasopressors was interesting as this situation is rare. Treatment of shock and hypotension is an area of neonatology where there is great uncertainty in identifying which patients would benefit from treatment.[@R32] Grouping the units provides an opportunity to observe differences and to reflect on practices. Nevertheless, it is interesting to note that for each practice except PDA treatment, differences between clusters, adjusted for the main confounders, were highly significant. Even if differences between each practice may be viewed as minimal, the association of small differences in different practices, leading to a team culture, appears to have an impact on health outcomes. Results also partly support our hypothesis. The highest implementation of neurodevelopmental care was observed in Cluster 1 which was also the cluster with the lowest proportions of conventional respiratory care, as well as low proportions of treatment with vasoactive amines or O-SH-GA. Cluster 3 was characterised by high conventional treatment rates but had the lowest rates of neurodevelopmental care provision. An interesting finding was the absence of differences in outcomes between Clusters 1 and 3. Patterns of care in Cluster 3 could be defined as more invasive than in Cluster 1. This may suggest an overuse of care in Cluster 3 and thus could offer opportunities for decreasing adverse effects and reducing unnecessary spending in such units. This could also mean that some babies are exposed to needless days of intensive care, increasing the risk of adverse effects associated with care and of interference with bonding and attachment.[@R33] Identification of Cluster 2 was less expected. It was characterised by increased use of screening practices for PDA and pain and this could generate new hypotheses. The lower mortality rate observed in Cluster 2 deserves attention. Our group has previously shown that systematic screening of PDA was associated with a lower mortality in neonates born between 24 and 29 WG[@R34] and we add a new perspective to this previous study. The difference in mortality should be explored in more detail but is somewhat counterbalanced by the increased number of children at risk of developmental delay at 2 years CA.

Implications for clinicians and policymakers {#s4-1}
--------------------------------------------

It has been proposed that greater reductions in morbidity may be achieved by concentrating on the best rather than the worst performing hospitals.[@R35] Our results highlight the difficulties in defining the 'best' hospitals when considering the complexity of neonatal care and interventional strategies to improve care developed in accordance with recently published guidelines should be explored.[@R36] Identifying patterns of care across NICUs appears to have the potential to reduce overuse and costs, and improve outcomes through the application of current medical knowledge early in life. The results also emphasise the complexity of neonatal care, demonstrate the difficulty of achieving high quality of care in every domain, and highlight the importance of well-resourced routine data collection and benchmarking.

Conclusion {#s5}
==========

This study, derived from a large national cohort, describes variations in patterns of care between NICUs associated with differences in outcomes for children born between 27 and 31 WG. Most of these variations are likely due to hospital organisations and clinical styles of practices. The interaction between patterns of care and regulatory, organisational and unit cultural factors should be investigated in more detail to better understand pathways of care implementation in everyday practice.
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